COOThe Cooper Companies
$62.37-11% 1Y
$62.37
$53.7052 weeks$84.32
Growth
Is COO growing?
The Cooper Companies's revenue has grown 6.4% a year over three years, and grown 8.3% a year over five, with earnings per share compounding at 28%.
+6.4%
Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +9.0% · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +8.3%
Revenue growth, 5-year rate · +6.4% over three · the three-year rate is below the five-year rate
- Earnings per share, 3-year rate
- +28%
Earnings per share, 3-year rate · revenue +6.4% · earnings per share grew faster than revenue
- Years of annual history on file
- 18
Years of annual history on file · FY2008 to FY2025, as filed
Details›
- Revenue FY2021
- $2.92B
- Revenue FY2022
- $3.31B
- Revenue FY2023
- $3.59B
- Revenue FY2024
- $3.90B
- Revenue FY2025
- $4.09B
Annual income statements as filed with the SEC.
Where the revenue comes from
14 quarters, Jan 2023 to Apr 2026Toric And Multifocal, quarter to Apr 2026from $261.6M in Jan 2023$364.9M
Toric And Multifocal$364.9M
Sphere Other$358.6M
Office And Surgical$214.2M
Fertility$143.8M
On our screensFree cash flow yield of 5 to 30 percent
Medical Instruments & Supplies
The closest names by size in the same industry